A significant association between high cytoplasmic THRβ1 expression with longer BC-specific survival (p < 0.0001) was found and maintained in a multivariable model adjusting for age, tumor size, nodal status, ER status, and treatment variables. This evidence concerns the gene THRB and breast cancer.